Pharma-K20
Natural health product licensed in Canada
- Licence holder
- Pharmascience Inc. / Pendopharms, Division of Pharmascience Inc.
- NPN or DIN-HM
- 80040416
- Status
- Active licence
- Licence date
- 27 February 2013
- Revision date
- 7 December 2016
- Form
- Comprimé à libération progressive
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Potassium Source : Chlorure de potassium | 780 mg | Not calculated |
Non-medicinal ingredients
Macrogol 1 500, Dioxyde de silicium colloïdal, Hypromellose, Copolymère d'acide méthacrylique, Poly(alcool vinylique), Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Comprimé ; maximum: 2 Comprimé | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Supplément de potassium pour le traitement ou la prévention de l'hypokaliémie (déficit en potassium) non attribuable à une carence alimentaire. Traitement de remplacement du potassium. Traitement pour la recharge électrolytique.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80040416
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging